Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction

Cilostazol, an antiplatelet drug that also may inhibit smooth muscle proliferation, was given together with aspirin after primary stenting to treat patients with acute myocardial infarction. In a randomized controlled trials of 50 patients, clinical and angiographic outcome at 6 months was significa...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1999-11, Vol.84 (9), p.1074-1076
Main Authors: Ochiai, Masahiko, Eto, Koji, Takeshita, Satoshi, Yokoyama, Naoyuki, Oshima, Akio, Kondo, Kiyoyuki, Sato, Tomohide, Isshiki, Takaaki
Format: Article
Language:English
Subjects:
Adult
Aged
Angioplasty, Balloon, Coronary
Aspirin - administration & dosage
Aspirin - adverse effects
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Cardiology
Cilostazol
Clinical outcomes
Coronary Angiography - drug effects
Drug therapy
Female
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - adverse effects
Heart attacks
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - therapy
Pharmacology. Drug treatments
Premedication
Stents
Tetrazoles - administration & dosage
Tetrazoles - adverse effects
Ticlopidine - administration & dosage
Ticlopidine - adverse effects
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cilostazol, an antiplatelet drug that also may inhibit smooth muscle proliferation, was given together with aspirin after primary stenting to treat patients with acute myocardial infarction. In a randomized controlled trials of 50 patients, clinical and angiographic outcome at 6 months was significantly improved with cilostazol, depicting a significantly smaller late loss and/or loss index.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(99)00501-9